Pricing Log in Create free account

Galecto, Inc. (DMRA) vs LB Pharmaceuticals Inc (LBRX)

Galecto, Inc. and LB Pharmaceuticals Inc are both Biotechnology companies. Galecto, Inc. and LB Pharmaceuticals Inc are of similar size ($1.2B and $1.2B). Across the 9 metrics below, Galecto, Inc. leads on 7 and LB Pharmaceuticals Inc on 2.

Valuation

Metric DMRA LBRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.92 3.33 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (816.76%) (9.36%) (33.15%)
Free cash flow yield (3.96%) (7.48%) (25.50%)

Profitability

Metric DMRA LBRX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (26.26%) (72.07%) (56.36%)
Return on assets (18.64%) (47.38%) (48.04%)
Return on invested capital 0.00% (1,304.79%) 0.00%

Growth

Metric DMRA LBRX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (730.84%) 98.22% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DMRA LBRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.73 15.08 4.72
Net debt to EBITDA 1.22 9.90 0.96

Dividend

Metric DMRA LBRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DMRA LBRX Biotechnology median
Market cap 1.16b 1.18b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack